Italy suspended the use of a flu vaccine made by Swiss pharmaceuticals giant Novartis on Thursday amid fears it may have caused three deaths.
In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University ...
An international team of researchers has shown that it may be possible to improve the effectiveness of the seasonal flu vaccine by 'pre-empting' the evolution of the influenza virus.
Together with a team at the Erasmus Medical Center in Rotterdam, LMU researchers have developed a candidate vaccine directed against the avian flu virus H5N1 and have now carried out the first tests in humans.
(HealthDay)—This year's flu season is off to a slow but detectable start. And it appears to be a typical one that's likely to peak in January or February, a leading U.S. health official says.
Early tests in mice carried out by the research team have shown that the compound restores the immune system's inbuilt 'memory', enabling the body to mount a more powerful protective immune response following ...
Leaders of the nation's system for helping people injured by vaccinations are vowing to better publicize the little-known program.
Amidst fears about the Ebola virus, the current flu season is gaining steam. And many Americans, while completely safe from Ebola, are in danger of becoming seriously ill with a widespread, highly infectious and potentially ...
Health officials say the nasal spray version of the flu vaccine did not protect young children against swine flu last winter and might not work again this year.
After weeks of Ebola panic, false alarms and quibbles over quarantine in the United States, health authorities are bracing for a new battle: flu season.